Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 445

1.

[FLT3 mutations in children with acute myeloid leukemia: a single center study].

Ruan M, Wang YQ, Zhang L, Liu TF, Liu F, Liu XM, Zhang JY, Zou Y, Chen YM, Zhu XF.

Zhongguo Dang Dai Er Ke Za Zhi. 2011 Nov;13(11):863-6. Chinese.

2.

FLT3 and NPM1 gene mutations in childhood acute myeloblastic leukemia.

Mukda E, Pintaraks K, Sawangpanich R, Wiangnon S, Pakakasama S.

Asian Pac J Cancer Prev. 2011;12(7):1827-31.

3.

[Prevalence and clinical significance of FLT3 mutations in acute promyelocytic leukemia].

Xue MX, Qiu HY, Feng YF, Zhu ZL, Chang WR, Liang JY, Chen SN, Cen JN, Xue YQ, Liu YJ, Sun AN, Wu DP.

Zhonghua Xue Ye Xue Za Zhi. 2008 Nov;29(11):757-61. Chinese.

PMID:
19176014
4.

[Detection of point mutation at second tyrosine kinase domain of FLT3 gene in acute myeloid leukemia].

Wang LH, Wang M, Zhou CL, Chen S, Zhang XW, Xing HY, Wang JX.

Zhonghua Xue Ye Xue Za Zhi. 2005 Jun;26(6):335-8. Chinese.

PMID:
16185475
5.

Low frequency and variability of FLT3 mutations in Korean patients with acute myeloid leukemia.

Bang SM, Ahn JY, Park J, Park SH, Park J, Cho EK, Shin DB, Lee JH, Yoo SJ, Jeon IS, Kim YK, Kim HJ, Kim HN, Lee IK, Kang HJ, Shin HY, Ahn HS.

J Korean Med Sci. 2008 Oct;23(5):833-7. doi: 10.3346/jkms.2008.23.5.833.

6.

[Flt-3/ITD mutation in pediatric leukemia and its clinical significance].

Wang J, Wang T, Li S, Lin L, Gang Y.

Ai Zheng. 2007 Jan;26(1):58-63. Chinese.

PMID:
17222369
7.

[Correlation of FLT3 gene expression level and internal tandem duplication mutation in acute myeloid leukemia and its clinical significance].

Wang YG, Liu XH, Liang Y, Jin J.

Zhonghua Xue Ye Xue Za Zhi. 2008 Nov;29(11):741-5. Chinese.

PMID:
19176010
8.

[FMS-like tyrosine kinase 3 gene mutations in acute myeloid leukemia].

Han YL, Zhang SJ, Qiao C, Dai D, Sun XM, Xu YL, Qian SX, Xu W, Wang JS, Li JY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Oct;17(5):1135-9. Chinese.

PMID:
19840437
9.

Specific pattern of protein expression in acute myeloid leukemia harboring FLT3-ITD mutations.

Scholl S, Melle C, Bleul A, Spies-Weisshart B, Kunert C, Höffken K, von Eggeling F.

Leuk Lymphoma. 2007 Dec;48(12):2418-23.

PMID:
18067018
10.

FLT3-TKD mutation in childhood acute myeloid leukemia.

Liang DC, Shih LY, Hung IJ, Yang CP, Chen SH, Jaing TH, Liu HC, Wang LY, Chang WH.

Leukemia. 2003 May;17(5):883-6.

PMID:
12750701
11.

Clinical relevance of internal tandem duplication of the FLT3 gene in childhood acute myeloid leukemia.

Liang DC, Shih LY, Hung IJ, Yang CP, Chen SH, Jaing TH, Liu HC, Chang WH.

Cancer. 2002 Jun 15;94(12):3292-8.

12.

Association of cup-like nuclei in blasts with FLT3 and NPM1 mutations in acute myeloid leukemia.

Park BG, Chi HS, Jang S, Park CJ, Kim DY, Lee JH, Lee JH, Lee KH.

Ann Hematol. 2013 Apr;92(4):451-7. doi: 10.1007/s00277-012-1645-5.

PMID:
23238897
13.

High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study Group.

Shimada A, Taki T, Koga D, Tabuchi K, Tawa A, Hanada R, Tsuchida M, Horibe K, Tsukimoto I, Adachi S, Kojima S, Hayashi Y.

Int J Hematol. 2012 Oct;96(4):469-76. doi: 10.1007/s12185-012-1163-1.

PMID:
22915059
14.

FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India.

Ghosh K, Swaminathan S, Madkaikar M, Gupta M, Kerketta L, Vundinti B.

Ann Hematol. 2012 Nov;91(11):1703-12. doi: 10.1007/s00277-012-1509-z.

PMID:
22733614
15.

Meta-analysis for the potential application of FLT3-TKD mutations as prognostic indicator in non-promyelocytic AML.

Li W, Zhang L, Huang L, Mi Y, Wang J.

Leuk Res. 2012 Feb;36(2):186-91. doi: 10.1016/j.leukres.2011.08.014.

PMID:
21907407
16.

Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML).

Schneider F, Hoster E, Schneider S, Dufour A, Benthaus T, Kakadia PM, Bohlander SK, Braess J, Heinecke A, Sauerland MC, Berdel WE, Buechner T, Woermann BJ, Feuring-Buske M, Buske C, Creutzig U, Thiede C, Zwaan MC, van den Heuvel-Eibrink MM, Reinhardt D, Hiddemann W, Spiekermann K.

Ann Hematol. 2012 Jan;91(1):9-18. doi: 10.1007/s00277-011-1280-6.

PMID:
21744003
17.

Mutation of FLT3 gene in acute myeloid leukemia with normal cytogenetics and its association with clinical and immunophenotypic features.

Chauhan PS, Bhushan B, Mishra AK, Singh LC, Saluja S, Verma S, Gupta DK, Mittal V, Chaudhry S, Kapur S.

Med Oncol. 2011 Jun;28(2):544-51. doi: 10.1007/s12032-010-9485-4.

PMID:
20354824
18.

Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia.

Colovic N, Tosic N, Aveic S, Djuric M, Milic N, Bumbasirevic V, Colovic M, Pavlovic S.

Ann Hematol. 2007 Oct;86(10):741-7.

PMID:
17579862
19.

Prognostic significance of foetal-like tyrosine kinase 3 mutation in Egyptian children with acute leukaemia.

Al-Tonbary Y, Mansour AK, Ghazy H, Elghannam DM, Abd-Elghaffar HA.

Int J Lab Hematol. 2009 Jun;31(3):320-6. doi: 10.1111/j.1751-553X.2008.01039.x.

PMID:
18336585
20.

[Prevalence and clinical significance of FLT3 internal tandem duplication mutation in acute leukemia].

Wang LH, Zhou CL, Zhang XW, Chen S, Wang M, Wang JX.

Zhonghua Xue Ye Xue Za Zhi. 2004 Jul;25(7):393-6. Chinese.

PMID:
15355689
Items per page

Supplemental Content

Support Center